ARCHIVES

ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals

This article is from The Cancer Letter archive.

Vol. 39 No. 35 | September 20, 2013

Download PDF Visit The Full Archive

Related Articles

Simmons Cancer Center at UT Southwestern Wins NCI Comprehensive Designation and $7.5 Million.

September 10, 2010

Capitol Hill: Senate bill would allow sale of therapies for catastrophic illness after phase I trials.

December 2, 2005

Health Care Reform: Fundamental changes Ahead For Cancer Research And Care

October 8, 1993

Shubick Blasts Tobacco Industry Scientists

October 4, 1974

Breast Cancer Coalition Plans Petition Urging Comprehensive Strategy

May 14, 1993

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

April 4, 1980